JP2005502616A5 - - Google Patents

Download PDF

Info

Publication number
JP2005502616A5
JP2005502616A5 JP2003508379A JP2003508379A JP2005502616A5 JP 2005502616 A5 JP2005502616 A5 JP 2005502616A5 JP 2003508379 A JP2003508379 A JP 2003508379A JP 2003508379 A JP2003508379 A JP 2003508379A JP 2005502616 A5 JP2005502616 A5 JP 2005502616A5
Authority
JP
Japan
Prior art keywords
disease
neuropathy
injury
diseases
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003508379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502616A (ja
JP4434729B2 (ja
Filing date
Publication date
Priority claimed from US09/893,344 external-priority patent/US6835711B2/en
Application filed filed Critical
Publication of JP2005502616A publication Critical patent/JP2005502616A/ja
Publication of JP2005502616A5 publication Critical patent/JP2005502616A5/ja
Application granted granted Critical
Publication of JP4434729B2 publication Critical patent/JP4434729B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003508379A 2001-06-28 2002-06-27 神経保護治療法のためのポリ−Glu,Tyrとこれで処理したT細胞の使用 Expired - Fee Related JP4434729B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/893,344 US6835711B2 (en) 2001-06-28 2001-06-28 Use of poly-Glu,Tyr for neuroprotective therapy
PCT/IL2002/000517 WO2003002140A1 (en) 2001-06-28 2002-06-27 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy

Publications (3)

Publication Number Publication Date
JP2005502616A JP2005502616A (ja) 2005-01-27
JP2005502616A5 true JP2005502616A5 (https=) 2006-01-05
JP4434729B2 JP4434729B2 (ja) 2010-03-17

Family

ID=25401407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003508379A Expired - Fee Related JP4434729B2 (ja) 2001-06-28 2002-06-27 神経保護治療法のためのポリ−Glu,Tyrとこれで処理したT細胞の使用

Country Status (15)

Country Link
US (1) US6835711B2 (https=)
EP (1) EP1406650B1 (https=)
JP (1) JP4434729B2 (https=)
KR (1) KR20040032825A (https=)
CN (1) CN1326560C (https=)
AT (1) ATE412419T1 (https=)
AU (1) AU2002345323B2 (https=)
CA (1) CA2451521C (https=)
DE (1) DE60229639D1 (https=)
DK (1) DK1406650T3 (https=)
ES (1) ES2315371T3 (https=)
IL (1) IL159535A0 (https=)
MX (1) MXPA03011926A (https=)
NZ (1) NZ530261A (https=)
WO (1) WO2003002140A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060266A2 (en) * 2003-01-07 2004-07-22 Yeda Research And Development Co. Ltd. Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization
US7399740B2 (en) * 2001-06-28 2008-07-15 Yeda Research And Development Co. Ltd. Poly-Glu,Tyr for neuroprotective therapy
US7351686B2 (en) * 2001-12-06 2008-04-01 Yeda Research And Development Co. Ltd. Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides
EP1645183B1 (en) 2003-06-16 2013-03-13 Kyushu University, National University Corporation Process for producing human-origin immunocompetent cell
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
WO2005055920A2 (en) * 2003-12-09 2005-06-23 Yeda Research And Development Co. Ltd. Compositions and methods for treatment of psychiatric disorders
JP4808631B2 (ja) * 2003-12-09 2011-11-02 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 精神医学的障害の治療用のコポリマー1を含む方法及びワクチン
ES2541780T3 (es) * 2004-11-29 2015-07-24 Yeda Research And Development Co., Ltd. Inducción de la neurogénesis y terapia con células madre en combinación con el Copolímero 1
US9220813B2 (en) * 2005-04-18 2015-12-29 Holy Cross Hospital, Inc. Cell therapy for limiting overzealous inflammatory reactions in tissue healing
US20100272787A1 (en) * 2007-12-21 2010-10-28 Ben Gurion University Of The Negev Amethod of treating neurodegenerative diseases
EP2349028A1 (en) * 2008-04-04 2011-08-03 The Cleveland Clinic Foundation Use of epineural sheath grafts for neural regeneration and protection
RU2369376C1 (ru) * 2008-04-30 2009-10-10 Государственное образовательное учреждение высшего профессионального образования Смоленская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию Способ стимуляции речевой активности у больных детским церебральным параличом
BRPI0923177A2 (pt) * 2008-12-19 2020-08-25 Advanced Technologies And Regenerative Medicine, Llc usos de composições para tratar dor neuropática e espacidade, as referidas composições, e kit
SG174551A1 (en) 2009-03-26 2011-10-28 Ethicon Inc Human umbilical cord tissue cells as therapy for alzheimer' s disease
EP2473193A4 (en) * 2009-09-04 2013-05-01 Cleveland Clinic Foundation METHOD OF NERVE TISSUE MANIPULATION
US8377885B2 (en) 2010-01-04 2013-02-19 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
HUE060304T2 (hu) 2010-01-04 2023-02-28 Mapi Pharma Ltd Glatiramer acetátot tartalmazó depó rendszer
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
WO2012143924A1 (en) 2011-04-21 2012-10-26 Mapi Pharma Ltd. Random pentapolymer for treatment of autoimmune diseases
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
CN109982712A (zh) 2016-08-31 2019-07-05 Mapi医药公司 包含醋酸格拉替雷的储库系统
CN110382052A (zh) 2017-03-26 2019-10-25 Mapi医药公司 用于治疗进展型形式的多发性硬化症的格拉替雷储库系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500199A (ja) 1998-07-21 2002-01-08 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 活性化t細胞、及びそれらの用途

Similar Documents

Publication Publication Date Title
JP2005502616A5 (https=)
CA2451521A1 (en) Use of poly-glu, tyr for neuroprotective therapy
IL169552A (en) Eye-drop vaccine containing copolymer 1 for systemic neuroprotection
JP2006515870A5 (https=)
Silver Inhibitory molecules in development and regeneration
JP2021075556A5 (https=)
JP2019167381A5 (https=)
JP2004507460A5 (https=)
JP2007500757A5 (https=)
BG106227A (en) Thiazolo derivatives and pharmaceutical compositions containing them
WO2008096271A3 (en) Neuroprotection in demyelinating diseases
PT1259477E (pt) Derivados de aminoadamantano como agentes terapeuticos
US20140107037A1 (en) Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
WO2004110389A3 (en) Sigma ligands for neuronal regeneration and functional recovery
MX2009012430A (es) Amidas disustituidas para mejorar las respuestas sinapticas glutamatergicas.
JP2009530237A5 (https=)
MX2010001631A (es) Amidas biciclicas para mejorar las respuestas sinapticas glutamatergicas.
JP2008521796A5 (https=)
WO2007127393A3 (en) Treatment and screening methods for promoting neurogenesis
WO2004089369A3 (en) Methods and means for treating protein conformational disorders
US7338976B1 (en) Heterocyclic esters or amides for vision and memory disorders
BRPI0508952A (pt) composto, formulação farmacêutica, uso de um composto, processo para a preparação de compostos, e, método para tratar doença
JP2016522830A5 (https=)
WO2003030836A3 (en) Neuronal regeneration
Su et al. Study on the optimal concentration of topical mitomycin-C in preventing postlaminectomy epidural adhesion